74 Publications (Page 3 of 3)
2009
Novel Monoclonal Antibody Enhances Natural Killer (NK) Cell Cytotoxicity against Multiple Myeloma (MM): Interim Phase 1 Trial Results
Benson, Don⋅Benson, Don⋅Hofmeister, Craig C⋅Hofmeister, Craig C⋅Padmanabhan, Swaminathan⋅Padmanabhan, Swaminathan⋅Abonour, Rafat⋅Abonour, Rafat⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Mita, Alain⋅Mita, Alain⋅Squiban, Patrick⋅Squiban, Patrick⋅Smith, Megan K⋅Smith, Megan K⋅Bakan, Courtney E⋅Bakan, Courtney E⋅Marzetto, Marc⋅Marzetto, Marc⋅Andre, Pascale⋅Andre, Pascale⋅Tollier, Jerome⋅Tollier, Jerome⋅Caligiuri, Michael A⋅Caligiuri, Michael A⋅Farag, Sherif and Farag, Sherif
Blood, vol. 114, (no. 22), pp. 2880, 2009-11-20. | Journal Article
 
Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Farag, Sherif⋅Farag, Sherif⋅O'Bryant, Robin A⋅O'Bryant, Robin A⋅Wood, Lisa L⋅Wood, Lisa L⋅Abonour, Rafat and Abonour, Rafat
Blood, vol. 114, (no. 22), pp. 2882, 2009-11-20. | Journal Article
 
The Role of the Antiapoptotic Protein c-FLIP in Multiple Myeloma
Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Zhang, Genglin⋅Zhang, Genglin⋅Zhang, Genglin⋅VanRyckeghem, Lauren B⋅VanRyckeghem, Lauren B⋅VanRyckeghem, Lauren B⋅Hanenberg, Helmut⋅Hanenberg, Helmut⋅Hanenberg, Helmut⋅Farag, Sherif⋅Farag, Sherif⋅Farag, Sherif⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya and Suvannasankha, Attaya
Blood, vol. 114, (no. 22), pp. 1966, 2009-11-20. | Journal Article
 
Transcriptional Repression of DAPK1 Characterizes a Resistant Phenotype of AML Enforced by Flt3 Signaling and Exclusive Nuclear Abundance of Non-Canonical NFkB2/p52: Synergistic Activity for Flt3 Inhibition along with HDAC Inhibition, or by NFkB Inhibition, for Potentiating ER Stress Apoptosis
Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Wilson-Weekes, Annique⋅Wilson-Weekes, Annique⋅Sayar, Hamid⋅Sayar, Hamid⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Cardoso, Angelo A⋅Cardoso, Angelo A⋅Sargent, Katie J⋅Sargent, Katie J⋅Cripe, Larry D⋅Cripe, Larry D⋅Kalvakolanu, Dhananjaya V⋅Kalvakolanu, Dhananjaya V⋅Boswell, H. Scott and Boswell, H. Scott
Blood, vol. 114, (no. 22), pp. 2387, 2009-11-20. | Journal Article
2008
Antimyeloma Effects of a Sesquiterpene Lactone Parthenolide
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin⋅Crean, Colin⋅Crean, Colin D⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Farag, Sherif⋅Farag, Sherif S⋅Farag, Sherif⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Boswell, H.⋅Boswell, HScott⋅Boswell, H.⋅Nakshatri, Harikrishna⋅Nakshatri, Harikrishna and Nakshatri, Harikrishna
Clinical Cancer Research, vol. 14, (no. 6), pp. 1814-1822, 2008. | Journal Article
 
Deep Vein Thrombosis and Pulmonary Embolism in Cirrhosis Patients
Gulley, David⋅Teal, Evgenia⋅Suvannasankha, Attaya⋅Chalasani, Naga P and Liangpunsakul, Suthat
Digestive Diseases and Sciences, vol. 53, (no. 11), pp. 3012-7, Nov 2008. | Journal Article
 
Differential Maintenance of Cell Cycle Status of Human Bone Marrow- and Umbilical Cord Blood-Derived CD34+ Cells after Homing to the Bone Marrow Microenvironment
Poteat, Bradley A⋅Poteat, Bradley A⋅Poteat, Bradley A⋅Chitteti, Brahmananda Reddy⋅Chitteti, Brahmananda Reddy⋅Chitteti, Brahmananda Reddy⋅Pollok, Karen E⋅Pollok, Karen E⋅Pollok, Karen E⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Srour, Edward F⋅Srour, Edward F and Srour, Edward F
Blood, vol. 112, (no. 11), pp. 1327, 2008-11-16. | Journal Article
 
Gastrointestinal plasmacytoma presenting as gastrointestinal bleeding.
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Cummings, Oscar W⋅Cummings, Oscar W⋅Cummings, Oscar W⋅Liangpunsakul, Suthat⋅Liangpunsakul, Suthat and Liangpunsakul, Suthat
Clinical lymphoma & myeloma, vol. 8, (no. 5), pp. 309-11, 2008/Oct. | Journal Article
 
Synergistic Activity of Bendamustine in Combination with Doxorubicin and Bortezomib in Multiple Myeloma Cells
Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S and Farag, Sherif S
Blood, vol. 112, (no. 11), pp. 5171, 2008-11-16. | Journal Article
 
The Novel Aurora Kinase Inhibitor ENMD-2076 Has Potent Single Agent Activity against Multiple Myeloma (MM) in Vitro and in Vivo, and Shows Synergistic Activity in Combination with Lenalidomide
Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Wang, Xiaojing⋅Sinn, Anthony L⋅Sinn, Anthony L⋅Sinn, Anthony L⋅Sinn, Anthony L⋅Sinn, Anthony L⋅Sinn, Anthony L⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Chen, Li⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Liang, Jing⋅Zhang, Genglin⋅Zhang, Genglin⋅Zhang, Genglin⋅Zhang, Genglin⋅Zhang, Genglin⋅Zhang, Genglin⋅Pollok, Karen E⋅Pollok, Karen E⋅Pollok, Karen E⋅Pollok, Karen E⋅Pollok, Karen E⋅Pollok, Karen E⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Sidor, Carolyn⋅Bray, Mark R⋅Bray, Mark R⋅Bray, Mark R⋅Bray, Mark R⋅Bray, Mark R⋅Bray, Mark R⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S and Farag, Sherif S
Blood, vol. 112, (no. 11), pp. 3660, 2008-11-16. | Journal Article
2007
Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial, HEM01-21
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Fausel, Christopher⋅Fausel, Christopher⋅Juliar, Beth⋅Juliar, Beth E⋅Yiannoutsos, Constantin T⋅Yiannoutsos, Constantin⋅Fisher, William B⋅Fisher, William⋅Ansari, Rafat⋅Ansari, Rafat H⋅Wood, Lisa L⋅Wood, Lisa⋅Smith, Gina G⋅Smith, Gina⋅Cripe, Larry D⋅Cripe, Larry⋅Abonour, Rafat and Abonour, Rafat
Oncologist, vol. 12, (no. 1), pp. 99-106, 2007. | Journal Article
 
OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin⋅Crean, Colin D⋅Crean, Colin⋅White, Valerie⋅White, Valerie L⋅White, Valerie⋅Johnson, Amy⋅Johnson, Amy⋅Johnson, Amy⋅Chen, Ching Shih⋅Chen, Ching-Shih⋅Chen, Ching-Shih⋅Farag, Sherif⋅Farag, Sherif and Farag, Sherif S
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 13, (no. 16), pp. 4750-8, 2007/Aug/15. | Journal Article
2006
Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.
Hartman, Amy D⋅Wilson-Weekes, Annique⋅Suvannasankha, Attaya⋅Burgess, Gem S⋅Phillips, Carissa A⋅Hincher, Katie J⋅Cripe, Larry D and Boswell, H Scott
Experimental hematology, vol. 34, (no. 10), pp. 1360-1376, October 2006. | Journal Article
 
The Sesquiterpene Lactone Parthenolide Induces Apoptosis and Overcomes the Protective Effect of the Bone Marrow Microenvironment in Human Multiple Myeloma Cells
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Crean, Colin D⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Shanmugam, Rajasubramaniam⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Boswell, H. Scott⋅Boswell, H. Scott⋅Boswell, H. Scott⋅Boswell, H. Scott⋅Nakshatri, Harikrishna⋅Nakshatri, Harikrishna⋅Nakshatri, Harikrishna and Nakshatri, Harikrishna
Blood, vol. 108, (no. 11), pp. 5058, 2006-11-16. | Journal Article
 
Weekly Bortezomib/Methylprednisolone is Effective and Well Tolerated in Relapsed Multiple Myeloma
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Smith, GG⋅Smith, Gina G⋅Juliar, BE⋅Juliar, Beth E⋅Abonour, Rafat and Abonour, R.
Clinical Lymphoma & Myeloma, vol. 7, (no. 2), pp. 131-134, 2006. | Journal Article
2005
In AML, Cbl Serves as Nexus for Signaling from Flt3, and Is Required for Coupling JNK1 in a Pathway of Survival and Proliferation Involving c-jun/AP-1
Hartman, Amy D⋅Hartman, Amy D⋅Wilson-Weekes, Annique⋅Wilson-Weekes, Annique⋅Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Burgess, Gem S⋅Burgess, Gem S⋅Hincher, Kathryn J⋅Hincher, Kathryn J⋅Cripe, Larry D⋅Cripe, Larry D⋅Boswell, H. Scott and Boswell, H. Scott
Blood, vol. 106, (no. 11), pp. 1203, 2005-11-16. | Journal Article
 
Weekly Bortezomib with or without Glucocorticosteroids Is Effective in Patients with Relapsed or Refractory Multiple Myeloma
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Smith, Gina G⋅Smith, Gina G⋅Abonour, Rafat and Abonour, Rafat
Blood, vol. 106, (no. 11), pp. 2562, 2005-11-16. | Journal Article
2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function.
Suvannasankha, A⋅Minderman, H⋅O'Loughlin, K L⋅Nakanishi, T⋅Greco, W R⋅Ross, D D and Baer, M R
Leukemia, vol. 18, (no. 7), pp. 1252-1257, July 2004. | Journal Article
 
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survival.
Suvannasankha, Attaya⋅Minderman, Hans⋅O'Loughlin, Kieran L⋅Nakanishi, Takeo⋅Ford, Laurie A⋅Greco, William R⋅Wetzler, Meir⋅Ross, Douglas D and Baer, Maria R
British journal of haematology, vol. 127, (no. 4), pp. 392-8, 2004/Nov. | Journal Article
 
Expression of the neural cell adhesion molecule CD56 is not associated with P-glycoprotein overexpression in core-binding factor acute myeloid leukemia
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Minderman, Hans⋅Minderman, Hans⋅O'Loughlin, Kieran L⋅O’Loughlin, Kieran L⋅Sait, Sheila⋅Sait, Sheila N.J⋅Stewart, Carleton C⋅Stewart, Carleton C⋅Greco, William R⋅Greco, William R⋅Baer, Maria R and Baer, Maria R
Leukemia Research, vol. 28, (no. 5), pp. 455, 2004. | Journal Article
 
The Protein Kinase C beta (PKCβ) Inhibitor Enzastaurin HCl (LY317615) Augments Chemosensitivity of Multiple Myeloma (MM) Cells to Dexamethasone and the Proteasome Inhibitor Bortezomib
Suvannasankha, Attaya⋅Suvannasankha, Attaya⋅Xu, Dawei⋅Xu, Dawei⋅Abonour, Rafat and Abonour, Rafat
Blood, vol. 104, (no. 11), pp. 4382, 2004-11-16. | Journal Article
2003
Terbinafine-associated hepatotoxicity.
Ajit, Challa⋅Suvannasankha, Attaya⋅Zaeri, Nayere and Munoz, Santiago J
The American journal of the medical sciences, vol. 325, (no. 5), pp. 292-295, May 2003. | Journal Article
 
Terbinafine-Associated Hepatotoxicity
Ajit, Challa⋅Zaeri, Nayere⋅Munoz, Santiago J and Suvannasankha, Attaya
The American Journal of the Medical Sciences, vol. 325, (no. 5), pp. 295, May 2003. | Journal Article
2002
Flow cytometric analysis of breast cancer resistance protein expression and function.
Minderman, Hans⋅Suvannasankha, Attaya⋅O'Loughlin, Kieran L⋅Scheffer, George L⋅Scheper, Rik J⋅Robey, Robert W and Baer, Maria R
Cytometry, vol. 48, (no. 2), pp. 59-65, 2002/Jun/1. | Journal Article